The Aaron's Company, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AAN research report →
Range $10 – $19
Price Chart
About the company
The Aaron's Company, Inc. provides flexible acquisition options, allowing consumers to either lease-to-own or directly purchase a variety of goods. The company serves customers across the United States and Canada by distributing furniture, major appliances, electronics, computers, and related accessories through its corporate-owned stores, independently operated franchised outlets, and a robust e-commerce platform.
- CEO
- Douglas A. Lindsay
- IPO
- 2020
- Employees
- 9,071
- HQ
- Atlanta, GA, US
Get TickerSpark's AI analysis on AAN
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $318.35M
- P/E
- 112.11
- Fwd P/E
- 12.46
- PEG
- -0.23
- P/S
- 0.15
- P/B
- 0.45
- EV/EBITDA
- 1.48
- Div Yield
- 4.96%
- Gross Margin
- 52.31%
- Op Margin
- 0.59%
- Net Margin
- 0.13%
- ROE
- 0.41%
- ROIC
- -2.37%
Latest fiscal year · YoY change
- Revenue
- $2.14B-4.9%
- Gross Profit
- $1.12B-3.7%
- Op Income
- $12.55M
- Net Income
- $2.82M+153.5%
- EPS
- $0.09+152.9%
- OCF Growth
- +5.9%
- FCF Growth
- +37.7%
- 52W High
- $11.90
- 52W Low
- $6.62
- 50D MA
- $10.04
- 200D MA
- $9.11
- Beta
- 1.42
- RSI (14)
- 57
- Avg Volume
- 1.06M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Aaron’s delivered Q1 results in line with guidance, with improving lease momentum at Aaron’s offset by continued pressure at BrandsMart, and management reaffirmed full-year revenue and adjusted EBITDA outlook while raising EPS guidance on a lower tax rate.· May 7, 2024
- Aaron’s business showed clear momentum: lease merchandise deliveries rose 6.8%, e-commerce leases grew 20.8%, and same-store lease portfolio trends improved into April and May.
- BrandsMart beat internal expectations on revenue and adjusted earnings, but comparable sales were still down 9.4% amid weak demand and tighter credit conditions.
- Management reaffirmed full-year 2024 revenue and adjusted EBITDA guidance, and raised non-GAAP diluted EPS guidance because the estimated effective tax rate moved down to about 38%.
- Cash flow was pressured by higher inventory purchases to support growth, with adjusted free cash flow a $33.2 million use of cash in the quarter.
- The company said its lease portfolio inflection point should drive profitability in the second half of 2024 and into 2025, while still expecting write-offs to run above historical averages at 6% to 7% of lease revenues and fees.
Consolidated Q1 2024 revenue was $511.5 million, down from $554.4 million year over year. Consolidated adjusted EBITDA was $22.7 million versus $45.9 million a year ago, and non-GAAP loss per share was $0.15. Adjusted EBITDA margin was 4.4%. Adjusted free cash flow was a $33.2 million use of cash. At quarter end, cash was $41 million and total debt was $212.9 million. On the operating side, Aaron’s lease merchandise deliveries increased 6.8% year over year, lease renewal rate was 87.4%, 32-plus day nonrenewal rate was 2.2%, and write-off to lease revenues was 5.9%. BrandsMart comparable sales declined 9.4% year over year. For 2024, management reaffirmed full-year revenue and adjusted EBITDA outlook, raised non-GAAP diluted EPS guidance due to a lower estimated tax rate, now about 38%, and still expects full-year lease merchandise write-offs of 6% to 7% of lease revenues and fees.
Douglas Lindsay said the quarter was in line with guidance and that he is encouraged by the momentum in the business, especially at Aaron’s. He emphasized the success of the new omnichannel lease decisioning and customer acquisition program, saying it is driving higher conversion rates, stronger e-commerce growth, and an inflection point in the same-store portfolio. His tone was confident but measured: he acknowledged the demand environment remains challenging, especially at BrandsMart, while expressing optimism that portfolio growth should flow through to profitability in the second half of 2024 and into 2025.
Kelly Wall focused on the financial bridge and outlook. She said Q1 revenue of $511.5 million and adjusted EBITDA of $22.7 million were down year over year mainly because of lower revenues, higher other operating expenses, and higher write-offs, partly offset by lower personnel costs. She noted adjusted free cash flow was a $33.2 million use of cash due mainly to higher lease merchandise inventory purchases and lower earnings, though this was still favorable to internal expectations. On capital allocation, she reiterated a conservative leverage target of 1x to 1.5x net debt to adjusted EBITDA, plus dividends, repurchases, and opportunistic acquisitions; the quarterly dividend was set at $0.125 per share payable July 3. She also said cost savings initiatives are expected to deliver $30 million to $35 million this year and explained the EPS raise came from an estimated tax rate of about 38%, 12 points below prior guidance.
Analysts pressed on Aaron’s store optimization, the improving portfolio trend in April and May, BrandsMart demand, lease write-offs, average ticket, and consumer health. Management said it is actively rationalizing markets, closed 30 to 40 stores during the quarter, and prefers a flexible mix of full stores and smaller showrooms rather than committing to a fixed store count. On portfolio growth, management pointed to the omnichannel program, saying it is driving higher conversion and could add meaningful gross margin as the portfolio turns positive. They also said write-offs should remain in the 6% to 7% range for the year, with the current mix shift toward e-commerce affecting renewal and delinquency metrics. For BrandsMart, management said the second-half outlook depends on easier comparisons and an expected rebound in major categories, while noting private-label credit card tightening impacted roughly a little more than 25% of sales.
The bull case from this call is that Aaron’s core business appears to be inflecting: deliveries are growing, e-commerce is expanding rapidly, and management said same-store portfolio size has already turned positive versus last year. The company also believes that even modest portfolio growth should create significant flow-through to gross margin and EBITDA because of the business’s operating leverage.
The main risks are that demand remains weak in key categories, especially at BrandsMart, where comparable sales were still down 9.4% and traffic and trade-down pressures persisted. Cash flow was negative in the quarter, write-offs remain elevated versus historical levels, and management acknowledged that portfolio growth and profitability depend on continued execution in a still-challenging consumer environment.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 94.7%
- Shares Outstanding
- 31.55M
- Float Shares
- 29.87M
of shares held by institutions
144 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for AAN, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| David McKinleyHouse · WV01 | Sell | Mar 9, 20 | Filing → |
| David McKinleyHouse · WV01 | Sell | Mar 23, 20 | Filing → |
| David McKinleyHouse · WV01 | Buy | Jul 18, 19 | Filing → |
| David McKinleyHouse · WV01 | Buy | Jul 17, 19 | Filing → |
| David Alfred PerdueSenate | Sell | Jan 23, 15 | Filing → |
| David Alfred PerdueSenate | Sell | Feb 6, 15 | Filing → |
| David Alfred PerdueSenate | Sell | Feb 4, 15 | Filing → |
| David Alfred PerdueSenate | Sell | Jan 13, 15 | Filing → |
| David Alfred PerdueSenate | Sell | Jan 8, 15 | Filing → |
| David Alfred PerdueSenate | Sell | Feb 5, 15 | Filing → |
| David Alfred PerdueSenate | Sell | Jan 13, 15 | Filing → |
| David Alfred PerdueSenate | Sell | Jan 8, 15 | Filing → |
| David Alfred PerdueSenate | Sell | Feb 6, 15 | Filing → |
| David Alfred PerdueSenate | Sell | Feb 5, 15 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Blackrock Inc. | 3.51M | ▼ 683.23K |
| Crystalline Management Inc. | 177.12K | ▲ 100.44K |
| Putnam Investments LLC | 86.57K | ▲ 86.57K |
| Point72 Middle East Fze | 17.99K | ▲ 3.97K |
Held by 7 ETFs
Biggest fund positions in AAN by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 3, 24 | Bacdayan Wangdali | sell | 20,000 |
| Oct 3, 24 | Bacdayan Wangdali | sell | 30,679 |
| Oct 3, 24 | Robinson John W | sell | 291,065 |
| Oct 3, 24 | Robinson John W | sell | 22,253 |
| Oct 3, 24 | Moore Marvonia P | sell | 19,324 |
| Oct 3, 24 | Moore Marvonia P | sell | 24,680 |
| Oct 3, 24 | Malkoski Kristine Kay | sell | 30,679 |
| Oct 3, 24 | JOHNSON TIMOTHY A | sell | 20,000 |
| Oct 3, 24 | JOHNSON TIMOTHY A | sell | 42,041 |
| Oct 3, 24 | Harris Hubert L. Jr. | sell | 2,470 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our AAN coverage
Recent articles, reports, and earnings notes.
No research on AAN yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate AAN report →Kyverna Presents Registrational Trial Primary Analysis for Miv-cel in Stiff Person Syndrome Demonstrating Statistically Significant, Durable Clinical Benefit Across All Endpoints in an Oral, Late-Breaker Session at AAN Annual Meeting
globenewswire.com · Apr 21
Ionis presents new data from pivotal study of zilganersen in Alexander disease (AxD) at AAN 2026 Annual Meeting
businesswire.com · Apr 21
Kyverna Presents Longer-Term Phase 2 Data for Miv-cel in Generalized Myasthenia Gravis at AAN, Demonstrating Deep, Durable Responses through 52 Weeks
globenewswire.com · Apr 20
Xenon Presents Azetukalner Phase 3 X-TOLE2 Study Results and 48-Month Long-term Data in Focal Onset Seizures at 2026 AAN Annual Meeting
globenewswire.com · Apr 19
argenx Brings Neuromuscular Leadership to AAN 2026 with New Data Supporting Broader VYVGART Use Across MG and CIDP
globenewswire.com · Apr 18
Acadia Pharmaceuticals to Present Data at the 2026 American Academy of Neurology (AAN) Annual Meeting
businesswire.com · Apr 17
Lexicon to Present Data at the American Academy of Neurology (AAN) Annual Meeting
globenewswire.com · Apr 17
Alkermes to Present Additional Data From Vibrance-1 Phase 2 Study of Alixorexton in Patients with Narcolepsy Type 1 at the American Academy of Neurology (AAN) 2026 Annual Meeting
businesswire.com · Apr 16
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.